title: Symptomatic awareness of hypoglycaemia: does it change on transfer from animal to human insulin?
abstract: A retrospective survey of symptomatic awareness of hypoglycaemia was performed in 189 randomly selected patients with insulin-treated diabetes who had been transferred from highly purified animal insulins to human insulin in the preceding 24 months. Of the 189 patients 44 (23%) complained of chronic hypoglycaemic unawareness, unrelated to ambient blood glucose control, before change of insulin species. Only 12 of the remaining 145 patients reported a reduction in awareness of hypoglycaemia following transfer to human insulin (6% of the whole group), while 6 (3%) reported an increase in awareness following the transfer. The 12 patients reporting reduced awareness had a mean duration of diabetes of 24 +/ 10 years compared to a duration of 15 +/- 10 years in the patients with normal awareness. The mean glycosylated haemoglobin concentrations were similar in all of the groups of patients. Six patients had developed total loss of awareness of the onset of hypoglycaemia, with all but one patient having suffered multiple episodes of severe hypoglycaemia. This reduced hypoglycaemic awareness on human insulin therapy was not associated with any significant improvement in blood glucose control.
authors.affiliation: Diabetic Department, Royal Infirmary, Edinburgh, Scotland.
authors.forename: D A
authors.initials: DA
authors.lastname: Hepburn
authors.forename: D W
authors.initials: DW
authors.lastname: Eadington
authors.forename: A W
authors.initials: AW
authors.lastname: Patrick
authors.forename: N R
authors.initials: NR
authors.lastname: Colledge
authors.forename: B M
authors.initials: BM
authors.lastname: Frier
mesh_terms: D000328:Adult; D001364:Awareness; D003071:Cognition; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology / Q000503:physiopathology*; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011897:Random Allocation; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D007328:Insulin; D011994:Recombinant Proteins